BLENREP

Find important information about the FDA's withdrawal of the U.S. license to manufacture BLENREP and the discontinuation of the REMS program... On November 22, 2022, GSK announced the initiation of the withdrawal of the US marketing authorization for BLENREP... You are about to leave a GSK website. By clicking this link you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK and GSK is not responsible for its content.